Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Int J Dev Neurosci. 2017 Oct 27;65:66–82. doi: 10.1016/j.ijdevneu.2017.10.009

Figure 1.

Figure 1

Mean (± S.E.M) body weight across the various test days for HIV-1 proteins (A) Tat dose treatment and (B) gp120 dose treatment. No Tat or gp120 treatment effects were noted at any test set/day.